# CAMCEVI ETM
> **NDA219745** · New Drug Application · Sponsor: ACCORD · Approved 2025-08-25
## Drug
- **FDA Application Number:** NDA219745
- **Application type:** New Drug Application
- **Brand name:** CAMCEVI ETM
- **Generic name:** Leuprolide Mesylate
- **Active ingredients:** LEUPROLIDE MESYLATE
- **Dosage form:** EMULSION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD
- **First approval:** 2025-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219745)
---
*MORVS · CC0 1.0*